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PHeart Rhythm Disorders
ulmonary Vein Total Occlusion Following
atheter Ablation for Atrial Fibrillation
linical Implications After Long-Term Follow-Up
uigi Di Biase, MD,*† Tamer S. Fahmy, MD,* Oussama M. Wazni, MD,* Rong Bai, MD,*†
impi Patel, MD,* Dhanunjaya Lakkireddy, MD,* Jennifer E. Cummings, MD,*
obert A. Schweikert, MD,* J. David Burkhardt, MD,* Claude S. Elayi, MD,* Mohamed Kanj, MD,*
ucie Popova, MD,* Subramanya Prasad, MD,* David O. Martin, MD,* Lourdes Prieto, MD,*
alid Saliba, MD,* Patrick Tchou, MD,* Mauricio Arruda, MD,* Andrea Natale, MD*
leveland, Ohio; and Varese, Italy
OBJECTIVES We present the clinical course and management outcomes of patients with total pulmonary
vein occlusion (PVO).
BACKGROUND Pulmonary vein occlusion is a rare complication that can develop after radiofrequency catheter
ablation (RFA) of atrial fibrillation (AF). The long term follow-up data of patients diagnosed
with PVO are minimal.
METHODS Data from 18 patients with complete occlusion of at least one pulmonary vein (PV) were
prospectively collected. All patients underwent RFA for AF using different strategies between
September 1999 and May 2004. Pulmonary vein occlusion was diagnosed using computed
tomography (CT) and later confirmed by angiography when intervention was warranted.
Lung perfusion scans were performed on all patients before and after intervention. The
percent stenoses of the veins draining each independent lung were added together to yield an
average cumulative stenosis of the vascular cross-sectional area draining the affected lung
(cumulative stenosis index [CSI]).
RESULTS The patients’ symptoms had a positive correlation with the CSI (r  0.843, p  0.05) and
a negative one with the lung perfusion (r  0.667, p  0.05). A CSI 75% correlated well
with low lung perfusion (25%; r0.854, p 0.01). Patients with a CSI75% appeared
to improve mostly when early (r  0.497) and repeated dilation/stenting (r  0.0765) were
performed.
CONCLUSIONS Patients with single PVO are mostly asymptomatic and should undergo routine imaging. On
the other hand, patients with concomitant ipsilateral PV stenosis/PVO and a CSI 75%
require early and, when necessary, repeated pulmonary interventions for restoration of
pulmonary flow and prevention of associated lung disease. (J Am Coll Cardiol 2006;48:
ublished by Elsevier Inc. doi:10.1016/j.jacc.2006.08.0382493–9) © 2006 by the American College of Cardiology Foundation
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tulmonary vein occlusion (PVO), the most severe form of
ulmonary vein stenosis (PVS), is a clinically significant
omplication associated with radiofrequency catheter abla-
ion (RFA) of atrial fibrillation (AF) (1–5). In our previous
eries, we reported the incidence and functional character-
stics of pulmonary vein stenosis in its different degrees (6).
his study focuses on the subset of patients who progressed
o total occlusion. We report the long-term follow-up and
linical outcome and their relation with the radiologic and
hysiologic findings.
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hysiology and Pacing, Cleveland Clinic, Cleveland, Ohio; and the †Department of
ardiovascular Science, University of Insubria, Varese, Italy. Drs. Di Biase and Bai
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upported by a grant from the Department of Cardiology, Institute for Clinical and
xperimental Medicine, Prague, Czech Republic.t
Manuscript received June 28, 2006; revised manuscript received August 1, 2006,
ccepted August 8, 2006.ETHODS
atients. Data from 18 patients with complete occlusion of
t least 1 pulmonary vein (PV) were prospectively collected.
atients underwent RFA for AF (paroxysmal, persistent, or
ermanent) at our or other institutions between September
999 and May 2004. The preprocedural evaluations fol-
owed the local protocols approved by the Institutional
eview Board (Cleveland Clinic) and written consent was
btained from all patients. The demographics of the pa-
ients are listed in Table 1.
blation techniques. Pulmonary vein focal ablation, cir-
umferential electroanatomical ablation, ostial segmental
blation (distal isolation), and PV antrum isolation were
sed to treat AF in the 18 patients. The details of these
blation strategies were previously described elsewhere (7–
). In brief, the PV focal ablation technique was used in the
arlier experience of AF ablation, where foci arising from
he muscular sleeves of the PVs and triggering AF were
argeted. The RF energy was delivered inside the PVs.
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Pulmonary Vein Total Occlusion December 19, 2006:2493–9ircumferential ablation using the electroanatomical ap-
roach was used from 1999 to June 2000. Pulmonary vein
stial segmental ablation (distal isolation) was the predom-
nant technique applied at our center between 2000 and
003. By using this strategy, the PVs were isolated at their
stia at the PV-left atrial junction. The PV antrum isolation
echnique became the main approach by the end of 2003.
F energy was delivered with either a conventional 4-mm
r 8-mm tip ablation catheter, or with a closed irrigation
ool-tip ablation catheter. The initial ablation power setting
as 30 W, 55°C for the 4- and 8-mm ablation catheters or
0 W, 45°C for cool-tip ablation catheter. After ablation, all
atients were kept on oral anticoagulation with a controlled
nternational normalized ratio between 2 and 3.
omputed tomography scan. The diagnosis of PVO was
ade using computed tomography (CT) scanning. At our
nstitute, CT scans routinely are performed at 3 months
fter ablation follow-up evaluation or earlier if the patient
resents with symptoms consistent with PVS/PVO (In 7 of
he 18 patients, preprocedural CT was performed). Patients
ho underwent previous ablations at other institutions also
ad a preprocedural CT at our center to evaluate pre-
xisting PVO/PVS. Once PVS/PVO diagnosis was estab-
ished, serial CT scans were performed at 3-month intervals
r earlier if the patients developed new symptoms related to
able 1. Patient Demographics
ge, yrs (mean  SD) 49.3  11.8
ender (male), n (%) 14 (77)
ype of AF, n (%)
Paroxysmal/persistent 15 (83)
Permanent 3 (17)
nderlying heart disease, n
Ischemic heart disease 2
Dilated cardiomyopathy 1
Hypertrophic cardiomyopathy 1
Hypertensive heart disease 2
reexisting lung disease, n
Bronchial asthma 1
Fibrosing mediastinitis 1
o. of ablation, mean  SD 1.33  0.48
One procedure, n (%) 12 (66)
Two procedures, n (%) 6 (34)
chocardiography, n (%)
Left atrial dilation 4.5 mm 6 (34)
Ejection fraction 55% 3 (17)
Abbreviations and Acronyms
AF  atrial fibrillation
CSI  cumulative stenosis index
CT  computed tomography
NYHA  New York Heart Association
PPI  percutaneous pulmonary intervention
PV  pulmonary vein
PVO  pulmonary vein occlusion
PVS  pulmonary vein stenosis
RFA  radiofrequency catheter ablationtF  atrial fibrillation.VS/PVO. From 2002, multislice detector CT scanning
ith three-dimensional reconstruction of PVs and left
trium also was available for our patients. Pulmonary vein
cclusion is defined as 95% stenosis or complete loss of
atency of the PV on CT scan. The numbers of occluded
nd stenotic PVs were counted. By considering the total
enous drainage of each independent lung, the percentage of
tenosis of the affected veins on the same side were added
ogether to yield an average cumulative stenosis of the
ascular cross-sectional area draining the affected lung
cumulative stenosis index [CSI]). CSI  sum of percent
tenosis of the unilateral veins divided by the total number
f ipsilateral veins (usually two):
CSI
%Upper%Lower
Number of ipsilateral veins
V venogram and intervention. Once a PVO diagnosis
as established, a standard PV venogram was performed to
erify whether dilation or stenting of a severely stenotic or
ccluded vessel was possible. If a wire could traverse the
tenotic or occluded site, low-pressure balloon dilation of
he vein was attempted by applying the angioplasty tech-
ique. If the dilation was not satisfactory or a dissection
ccurred, PV stent was deployed in the same setting. Acute
uccess of the procedure was defined by improvement of PV
atency on angiography, whereas long-term success was
valuated by postprocedural CT and perfusion lung scans.
epeat pulmonary venogram and intervention were per-
ormed during the follow-up if necessary.
ung perfusion scan. Lung perfusion scans were per-
ormed to all patients before and after PV intervention. The
elative perfusion (%) of the different lung lobes was
valuated, and the relative perfusion of each independent
ung was compared with the number of occluded vessels and
he CSI. The relative perfusion values of affected lungs also
ere compared before and after PV dilation or stenting to
valuate the success of the intervention.
ymptom grading. Because of the diversity of respiratory
ymptoms in patients with PVO and because of the absence
f a current classification to grade such symptoms, we opted
o evaluate all the symptoms encountered and grade them
ccording to their severity. Symptoms included chest pain,
ough, dyspnea with variable New York Heart Association
NYHA) functional class, fever, and hemoptysis. We di-
ided our patients into 4 grades according to the severity/
umber of the aforementioned symptoms: grade 0 
symptomatic; grade 1  mild dyspnea, chest pain, or
ough; grade 2more than 1 symptom including moderate
yspnea on exertion, chest pain, or persistent cough; and
rade 3  severe symptoms such as dyspnea on mild
xertion or at rest, fever, productive cough, and hemoptysis.
he different relationships between the patients’ symptoms,he CSI, and the perfusion percentage were analyzed.
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December 19, 2006:2493–9 Pulmonary Vein Total Occlusionatient follow-up. The dates of the AF ablation, presen-
ation of symptoms, diagnosis of PVO, and the PV inter-
ention were identified. The progression of PVS/PVO in
ach patient was closely followed by analyzing changes in
ymptoms, CT findings, relative perfusion values, and
rawing correlations between them throughout the course
re- and post-PV intervention.
tatistical analysis. All continuous data were presented as
ean values  SD. Pearson’s correlation coefficient was
sed to evaluate the relation between the CSI and lung
erfusion, whereas categorical variables as symptom grading
nd number of procedures were correlated using Spearman’s
ank correlation coefficient (SPSS software version 11.0,
PSS Inc., Chicago, Illinois). Student paired t test was used
o evaluate the clinical significance where p values 0.05
ere considered significant.
ESULTS
atient presentation. Of 1,780 patients who underwent
FA for AF during the period of 1999 to 2004 at our
nstitution, 16 were found to have PVO of at least 1 PV,
hereas 2 additional patients were referred from other
nstitutions for further evaluation and management of
heir occluded PVs. The clinical presentation of these
atients was variable; 4 (22.2%) patients were totally
symptomatic throughout their course (grade 0), 2
11.1%) had mild symptoms of dry cough or dyspnea on
oderate/severe exertion (NYHA class I; grade 1), 4
22.2%) had moderate symptoms of dyspnea on mild
xertion (NYHA class II/III), together with persistent
ough (grade 2). Three (16.7%) patients had severe
ymptoms as severe dyspnea (NYHA class III/IV) with
emoptysis, fever, or pleuritic chest pain (grade 4) at their
nitial presentation, whereas 5 other patients (27.8%)
able 2. Number of Veins Affected in Each Patient With the As
raining Each Lung
Patients (n)
Total/Subtotal
Occlusion
Ipsilateral Vein
Stenosis
Other
Veins
4 1 0 0
4 1 1 (50%) 1
3 1 1 (50%) 0
2 1 1 (50%) 1
5 2 — 1he first 2 groups, having single vein occlusion with or without other insignificant stenosi
est having a CSI 75% are considered together.resented with mild or moderate symptoms but developed
evere symptoms along their course (grade 3).
The patients’ symptoms correlated with the underlying
ung findings. Of the 4 asymptomatic patients, 3 showed
o significant lung abnormalities at any time on CT, and
, who had baseline amiodarone-induced pneumonia,
howed no signs of new lung abnormalities. The 2
atients with grade 1 symptoms had either subsegmental
telectasis or areas of mild consolidation. The 4 patients
ith moderate symptoms (grade 2) had more prominent
bnormalities, including pulmonary congestion and sig-
ificant pleural effusion. Apart from 1, all 8 patients with
evere symptoms (grade 3) suffered severe lung disease,
ncluding pulmonary infarction (3 patients), severe pneu-
onia and pleural effusion (4 patients), and pulmonary
dema and alveolar hemorrhage in another patient. Of
nterest, in all these patients, the disease etiology was
issed or confused with other etiologies as pulmonary
mbolism for the pulmonary infarction and recent onset
sthma for the persistent bronchospasm. Furthermore, 2
atients received unnecessary intervention, such as place-
ent of an inferior vena caval filter for suspicion of
ulmonary embolism and partial lung resection for mis-
iagnosis of lung cancer.
iagnosis. The initial diagnosis of pulmonary vein ste-
osis by CT was within the first 3 months after the
blation procedure in 10 patients (66.7%), after 6 months
n 6 patients (22.2%), but was delayed in 2 patients up to
7 and 25 months because of loss at follow-up and
elayed referral. On the other hand, the mean time for
evelopment of total occlusion in one or more pulmonary
eins was 9.9 months (range 1 to 30 months) after
rogression of the lesions with or without symptom
ggravation.
ted Other Veins and the Total Stenosis Index of the Veins
CSI
Groupingtients (n) Left Veins (%) Right Veins (%)
2 45 0
1 50 0
1 0 50
1 50 20 75%
1 65 20
1 20 65
1 45 65
1 75 0
1 85 0
1 0 80
1 75 15 75%
1 75 25
1 90 0
3 100 0
1 100 30socia
Pas with cumulative stenosis index (CSI) 75%, are considered together, whereas the
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Pulmonary Vein Total Occlusion December 19, 2006:2493–9A total of 24 occluded veins were found in the 18 patients
y CT scan, with a mean of 1.4 veins per patient. Of these 24
ccluded veins, the left superior PV had the greatest incidence
f occlusion (54.2%), followed by the left inferior PV (29.2%),
ight inferior PV (8.3%), and the right superior PV (8.3%).
As shown in Table 2, of the 18 patients, 4 (27%) had
ingle vein occlusion with no other veins affected, whereas 4
dditional patients had other mild (50%) lesions in 1 or 2
ther PVs. Five patients (27%) had 2 totally occluded veins
n the same side, whereas 5 other had a single vein
cclusion with another significant ipsilateral vein stenosis
50%). Of these 5 patients, 3 had additional contralateral
ein stenosis as well.
The CSI was calculated in all patients. A strong positive
orrelation existed between the CSI and patients’ symptoms
efore intervention (r  0.843, p  0.001). A CSI of 75%
as found to correlate well with the severity of the disease
nd the presence of severe symptoms. Of the 8 patients
aving single-vein occlusion with or without other mild
esions (CSI75%) 4 were completely asymptomatic, 2 had
ild symptoms (grade 1), and only 2 had moderate symp-
oms (grade 2). On the other hand, all patients with a CSI
75% were symptomatic at the time of presentation, having
median of severe (grade 3) symptoms. Accordingly, our
atients were divided into 2 groups, those with a CSI75%
100  50%/2) and others with a CSI 75% (Table 2).
hysiologic evaluation. Lung perfusion scan was per-
ormed to all 18 patients before intervention. The mean
elative perfusion of the affected lung was 20.44  5.6%,
range 2% to 34%). The affected lung’s relative perfusion
howed a significant negative correlation with the patients
ymptoms (r  0.667, p  0.005). It was found that all
atients with severe symptoms had a relative perfusion
elow the value of 25%, whereas all asymptomatic patients
nd those with mild symptoms were above this value (Fig.
). The lung perfusion before pulmonary intervention also
igure 1. Variation of symptoms with lung perfusion. Scatter diagram
howing the relation between the symptoms and the degree of perfusion ofp
he affected lung indicating a negative correlation. As shown in the figure,
ll patients with grade 3 symptoms had a relative perfusion 25%.howed a significantly negative correlation with the CSI of
he corresponding veins (r  0.854, p  0.01) (Fig. 2).
ercutaneous pulmonary intervention. Pulmonary vein
ntervention was attempted in 17 out of the 18 patients.
annulation of the occluded vein failed in 2 cases. The
uccess of the procedure was evaluated by the decrease of the
umulative stenotic burden on the affected lung (detected by
T scan), as well as the improvement of the lung perfusion
ost intervention, where a strong positive correlation existed
etween improvements in the 2 variables (r  0.929, p 
.01).
The mean time from the diagnosis of total occlusion to
he percutaneous pulmonary intervention (PPI) was 4.53 
.6 (range 1 to 25) months and from the time of the last
FA before the occlusion was 8.9  6.32 (range 3 to 28)
onths. In addition, the mean time from total occlusion to
PI was significantly different between the successful and
ailed groups (2.58  1.88 months vs. 12.6  10.74
onths).
Importantly, the improvements in both the CSI and
erfusion had a significantly negative correlation with the
elay in intervention (time period from diagnosis of total
cclusion to intervention: r  0.497 and 0.473, respec-
ively, p  0.05) (Fig. 3).
Of the 15 attempted patients, 8 (54.3%) required PV
ilation and stent deployment for their occluded/stenosed
Vs, whereas in the other 7 patients (46.7%), only dilation
as attempted. A mean of 1.87  1.41 (range 1 to 6)
nterventions were performed for each patient. Of interest,
he number of intervention had a significant positive corre-
ation with the improvement of lung perfusion (r  0.765,
igure 2. Correlation between lung perfusion and cumulative stenosis
ndex (CSI). Scatter diagram showing the negative correlation between the
elative lung perfusion and the CSI. Patients are labeled by their symptom
rade. All patients having severe symptoms (grade 3) had a CSI75% and
relative perfusion of25% (located in the lower right quadrant), whereas
symptomatic patients or those having mild symptoms (grade 0 and 1,
espectively) had a CSI 75% and a relative perfusion 25% (located in
he upper left quadrant). S. grade  symptom grade (0  asymptomatic; 1
mild symptoms; 2  moderate; 3  severe). 0.001).
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December 19, 2006:2493–9 Pulmonary Vein Total OcclusionThe relief of cumulative stenosis was considerable in the
uccessful group, where the mean CSI decreased by 27.50%
fter intervention (95% confidence interval 11.73 to 43.27,
 0.005). On the other hand, the incidence of restenosis
n our patients was high (46%; 13 of 28 procedures done).
here was only one severe complication. In this patient,
ardiac perforation occurred when attempting to traverse a
otally occluded vein. The follow-up for all our patients
xtended beyond 14 months after the PPI. All patients were
symptomatic or had very mild symptoms, especially those
ho underwent successful intervention.
ISCUSSION
ain findings. Our study shows that although patients
ith single-vessel occlusion are mostly asymptomatic, pa-
ients with concurrent ipsilateral significant stenoses or
cclusion may present with diverse symptoms and corre-
ponding lung pathology that varies with the degree of the
SI and associated lung perfusion. A CSI 75% and a
elative perfusion 25% were found to be associated with
ailure of compensatory mechanisms, beyond which severe
ung pathology usually develops. As an extension to our
revious series, we emphasize that percutaneous interven-
ion is warranted for partial relief of the pulmonary flow.
inally, early intervention of the affected veins appears to be
f paramount importance to restore venous as well as arterial
ow to the corresponding lung.
natomic and physiologic considerations. Both the pul-
igure 3. Correlation between timing of intervention and perfusion
mprovement. The scatter diagram shows the relation between the time
rom pulmonary vein occlusion diagnosis to the time of intervention and
he improvement of the affected lung perfusion. Cases are labeled according
o the degree of improvement of the cumulative stenosis index as detected
y computed tomography scan. As shown, despite adequate restoration of
ascular patency, later interventions were not associated with a significant
mprovement of perfusion. CT imp. improvement of cumulative stenosis
ndex by computed tomography.onary venous and arterial systems are well known to be anterrelated (10–13). It has been shown that sudden occlusion
f a pulmonary vein is soon followed by gradual decline and
hen cessation of the arterial flow to the affected segment
12,14). This is caused by a decline in the arteriovenous
radient as well as compression by the developing tissue edema
10). As a consequence, the involved alveoli are affected by the
esulting ischemia and surrounding edema, leading to atelec-
asis, infarction, or susceptibility to infections (15). With the
esulting alterations in pulmonary hemodynamics, redistribu-
ion of blood flow occurs with opening of vascular channels or
eovascularization in which tissue hypoxia is known to play a
ole (12,14). Hence, the venous drainage of the affected
egment becomes mainly dependent on the ipsilateral veins
raining the healthy lobes. If the ipsilateral vein(s) is also
tenosed, the impedance to the pulmonary flow increases,
dding to the hemodynamic burden and the resulting lung
athology (16,17). Therefore, in case of progression to total
cclusion, we found that evaluating the ipsilateral vein involved
n this compensatory mechanism is of utmost importance for
imely intervention.
ulmonary vein occlusion. Our overall incidence for PVO
f 0.8% is lower than the previous 2.1% as reported by our
roup (6,18), which is similar to other studies in which
cclusion was reported to be 0.3% and 1.3% (4,19). The
ncidence in our series has decreased from 1.4% in 2000 to
.1% in 2004. This decline is attributed to change of the
blation strategy to antral isolation, the use of continuous
isualization by intracardiac echo, as well as the gain of
xperience.
ymptoms and corresponding lung diseases. All our pa-
ients with single-vein occlusion, even with concurrent
psilateral vein stenosis and with a CSI 75%, were either
symptomatic or only mildly symptomatic, which indicates
he success of their compensatory mechanism in prevention
f further sequelae. On the other hand, when the CSI was
75%, all patients had moderate-to-severe symptoms and
uffered lung-related diseases, including pneumonia, pleural
ffusion, and pulmonary infarction. Pulmonary findings
ere all associated with a corresponding decrease in the
erfusion of the affected segment of the lung, which
ndicates depletion of the compensatory mechanisms. This
nding is in line with the findings of other studies that have
sed lung scans and perfusion magnetic resonance for
ualitative evaluation of lung perfusion to assess the condi-
ion and to guide therapy (20). Moreover, quantitatively, we
ound a relative perfusion of25% in the affected lung to be
ndicative of the severity of symptoms and the correspond-
ng lung pathology, and associated with a CSI 75%.
Of the 18 patients, only 3 had pulmonary hypertension
t rest. This was only seen in the worst cases having 3 or
ore stenosed veins and was relieved after dilation. It was
hown in a recent study that despite the absence of
ulmonary hypertension at rest, there is lack of decline or
ven increase in pulmonary artery pressure with exercise
21). Although exercise testing was not routinely evalu-
ted, after a relatively long follow-up period, none of our
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Pulmonary Vein Total Occlusion December 19, 2006:2493–9atients had significant symptoms during moderate exer-
ion.
he importance of timely intervention. Of the 17 pa-
ients subjected to a dilation attempt, 9 were found to
ave totally occluded PVs by angiogram. In these cases
ntervention either failed or was aborted, and attention
as focused on the accompanying severe stenosis for
artial relief of the hemodynamic burden. On the other
and, in all other cases, every effort was undertaken to
raverse the lesion with subsequent dilation with or
ithout stenting. Of interest, the CT findings in some
ases tended to overestimate the extent of the stenotic
esions (6,22). This is an expected finding and may be due
o the differences of the injected-dye course between both
echniques. Such variation between the angio and CT,
lthough minor, is very critical. Indeed, complete occlu-
ion by CT scan should not be considered an exclusion
riterion for evaluation with PV angiogram and a possible
ilatation attempt. Magnetic resonance imaging may be
uperior to CT, although the presence of stents and its
elative higher cost hinders its use.
The duration from the time of diagnosis to the
ntervention varied among different patients, and was a
redictor of improvement of the lung perfusion post
ntervention. In fact, because of the delay in PV dilation
n some cases, the restoration of PV patency was not
ccompanied by a corresponding increase in pulmonary
erfusion (Fig. 3). In addition, the number of interven-
ions had a positive correlation with the improvement of
he lung perfusion. This emphasizes the high incidence
f restenosis and indicates that perseverance may be
orthwhile for the final outcome of procedure. In con-
ordance with other studies we found a high incidence of
estenosis despite stenting (22–25). On the contrary,
eumann et al. (23) had no incidence of restenosis after
tenting when using larger stents.
linical implications. Our study shows that PVO can
eflect slow and concealed progression of a previously
nsignificant narrowing. It is important to highlight the
outine use of imaging techniques post RFA of AF
ecause many patients with PVO are asymptomatic.
estoration of normal lung physiology depends on the
ime to intervention. Therefore, it is important not to
elay dilatation especially in patients with a CSI 75%.
ecause dilation of occluded PVs is less likely to be
uccessful, it may be preferable to dilate severely stenosed
V before they progress to complete occlusion.
tudy limitations. This study reports on a limited number
f cases; however, this is the largest series reported so far. In
his study CSI appeared to correlate with symptoms, lung
erfusion, and time to intervention. This index, although
aking physiological sense, has not been previously vali-
ated and further studies are required.
onclusions. Patients with single PVO are mostly asymp-
omatic. On the other hand, patients with concomitant ipsi-
ateral PVS/PVO carry a greater risk of developing severeymptoms and lung diseases when the cumulative stenosis of
he cross-sectional area of the pulmonary veins draining a
ingle lung is 75% and relative lung perfusion is 25%. In
hese patients, early and, when required, repeated PV inter-
ention should be considered for restoration of pulmonary flow
nd prevention of associated lung disease.
eprint requests and correspondence: Dr. Andrea Natale, De-
artment of Cardiovascular Medicine, Head, Section of Cardiac
lectrophysiology and Pacing, Cleveland Clinic, 9500 Euclid
venue, Cleveland, Ohio 44195. E-mail: natalea@ccf.org.
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